In today’s FridayScience we’re looking into the future: Nature Portfolio has published a list of clinical trials believed to shape medicine in 2024.
Among them, we see base editing for hypercholesterolemia, immunotherapy for melanoma, antibody–drug conjugate (ADC) for metastasis or a T cell vaccine for HIV. The inclusion of AI and personalized medicine in ClinicalTrials shows a shift from traditional approaches towards more innovative and patient-centered healthcare paradigms.
These trials have the potential for revolutionizing treatment approaches and might have transformative impact on healthcare practices worldwide.
